Document Detail


Long-term postplacement cost comparison of AneuRx and Zenith endografts.
MedLine Citation:
PMID:  18783917     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Long-term postplacement costs increase the global cost of endovascular aneurysm repair (EVAR) by 44%. Secondary procedures and endoleaks significantly increase long-term expense. This study evaluates device-specific long-term postplacement costs using two different endografts. AneuRx and Zenith endografts were used to treat 250 patients with abdominal aortic aneurysms between December 1998 and June 2006 at a single institution. A relative value unit-based hospital cost accounting system was used to calculate both direct and indirect hospital departmental costs. Institutional overhead expenses, costs of professional services, and outpatient visits were also included in cost determinations. All costs were valued in 2006 dollars. To examine long-term costs, patients with <1 year follow-up were excluded. The initial 50 EVAR patients between December 1995 and 1998 were also excluded, to limit the effect of the learning curve on postplacement cost. The cumulative 5-year postplacement costs per patient were $12,465 (AneuRx) and $10,606 (Zenith, p = 0.22). Mean durations of follow-up were 38.5 +/- 5.2 months (AneuRx) and 32.8 +/- 3.8 months (Zenith, p = 0.12). For both devices, the largest cost components were secondary procedures (59.5% AneuRx vs. 56.4% Zenith) and radiologic studies (29.2% AneuRx vs. 34.9% Zenith). Freedom from secondary procedures (80% vs. 51%, p < 0.05) and endoleaks (83% vs. 58%, p = 0.05) was higher in patients treated with Zenith vs. AneuRx endografts, respectively. There was a reduction in secondary procedures and endoleaks in patients treated with Zenith compared to AneuRx. The corresponding 15% reduction in cost, however, was not statistically significant. Additional device-related cost reductions may be possible through improvements in device and technique and alterations in surveillance imaging.
Authors:
Robert E Noll; Britt H Tonnessen; Jason Kim; Samuel R Money; W Charles Sternbergh
Related Documents :
10300047 - Medicare program; schedule of limits on home health agency costs per visit for cost rep...
12778567 - Economic feasibility evaluation of microfiltration of milk prior to cheesemaking.
12097017 - Entanglement cost of bipartite mixed states.
15839927 - A cost comparison of nephron-sparing surgical techniques for renal tumour.
10499117 - Counseling in audiology, or learning to listen: pre- and post-measures from an audiolog...
18468287 - Training to increase safe tray carrying among cocktail servers.
Publication Detail:
Type:  Comparative Study; Journal Article     Date:  2008-09-09
Journal Detail:
Title:  Annals of vascular surgery     Volume:  22     ISSN:  1615-5947     ISO Abbreviation:  Ann Vasc Surg     Publication Date:  2008 Nov 
Date Detail:
Created Date:  2008-11-10     Completed Date:  2009-01-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8703941     Medline TA:  Ann Vasc Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  710-5     Citation Subset:  IM    
Affiliation:
Section of Vascular Surgery, Ochsner Clinic Foundation, New Orleans, LA 70121, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Aortic Aneurysm, Abdominal / economics*,  radiography,  therapy*
Aortography / economics
Blood Vessel Prosthesis / economics*
Blood Vessel Prosthesis Implantation / adverse effects,  economics*,  instrumentation*
Cost-Benefit Analysis
Female
Hospital Costs*
Humans
Male
Prosthesis Design
Prosthesis Failure
Reoperation / economics
Retrospective Studies
Stents / economics*
Time Factors
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Closure of carotid artery puncture site with a percutaneous device.
Next Document:  The state of MIIND.